INTERNATIONAL JOURNAL
OF MEDICAL SCIENCES
ISSN NUMBER: 2692 - 5206
Volume 5,September,2025
38
UDC: 616.13-002.3:616.61-002.3:616.155.194
IMMUNE-HEMATOLOGICAL FEATURES OF NEPHROPATHY COMPLICATIONS
IN PATIENTS WITH HEMORRHAGIC VASCULITIS
Mamadaliyeva Hilolaxon Olimjon kizi,
Assistant of Hospital Pediatrics
https://orcid.org/0009-008-4296-5456
pediatr.hilolaxonolimjonovna@gmail.com
Andijan State Medical Institute
Abstract:
Hemorrhagic vasculitis (Henoch-Schönlein purpura) is the most common
manifestation of inflammation of the small vessels and may result in severe complications if
nephropathy develops. The aim of this study is to investigate the correlation between immune-
hematological markers and the development of nephropathy. Literature review demonstrates that
IgA immunoglobulins, the complement factors, cytokine levels, and alterations in platelet
function are determinants of nephropathy development. Results indicate that deposition of IgA
deposits in glomeruli, decreased C3 and C4 complement levels, increased levels of IL-6 and
TNF-α cytokines, and platelet function disorders correlate directly with nephropathy
development.
Keywords:
hemorrhagic vasculitis, nephropathy, immunoglobulin A, complement system,
cytokines, platelet activity
GEMORRAGIK VASKULITLI BEMORLARNI NEFROPATIYA BILAN
ASORATLANISHINING IMMUN-GEMATOLOGIK XUSUSIYATLARI
Annotatsiya.
Gemorragik vaskulit (Henoch-Schönlein purpurasi) kichik qon tomirlari
yallig'lanishining eng keng tarqalgan shakli bo'lib, nefropatiya rivojlanishi bilan og'ir
asoratlanishi mumkin. Ushbu tadqiqot immun-gematologik ko'rsatkichlar va nefropatiya
rivojlanishi o'rtasidagi bog'liqlikni tahlil qilishga qaratilgan. Adabiyotlar tahlili shuni ko'rsatdiki,
IgA immunoglobulinlari, komplement tizimi komponentlari, sitokin profillar va trombosit
faolligidagi o'zgarishlar nefropatiya rivojlanishida muhim rol o'ynaydi. Natijalarda IgA
depozitlarining glomerullarda to'planishi, C3 va C4 komplementlar darajasining pasayishi, IL-6
va TNF-α sitokillari kontsentratsiyasining ortishi hamda trombositlarning funktsional holatidagi
buzilishlar nefropatiya rivojlanishi bilan bevosita bog'liqligi aniqlandi.
Kalit so'zlar:
gemorragik vaskulit, nefropatiya, immunoglobulin A, komplement tizimi,
sitokinlar, trombosit faolligi
ИММУННО-ГЕМАТОЛОГИЧЕСКИЕ ОСОБЕННОСТИ ОСЛОЖНЕНИЙ
НЕФРОПАТИИ У БОЛЬНЫХ ГЕМОРРАГИЧЕСКИМ ВАСКУЛИТОМ
Аннотация.
Геморрагический васкулит (пурпура Шенлейна-Геноха) представляет
наиболее распространенную форму воспаления мелких сосудов и может привести к
INTERNATIONAL JOURNAL
OF MEDICAL SCIENCES
ISSN NUMBER: 2692 - 5206
Volume 5,September,2025
39
тяжелым осложнениям с развитием нефропатии. Данное исследование сосредоточено на
анализе
взаимосвязи
между
иммуно-гематологическими
параметрами
и
прогрессированием
нефропатии.
Анализ
литературы
демонстрирует,
что
иммуноглобулины IgA, компоненты системы комплемента, цитокиновые профили и
изменения активности тромбоцитов играют ключевые роли в развитии нефропатии.
Результаты указывают на то, что накопление депозитов IgA в клубочках, снижение
уровней комплементов C3 и C4, повышение концентраций цитокинов IL-6 и TNF-α, а
также функциональные нарушения тромбоцитов непосредственно связаны с
прогрессированием нефропатии.
Ключевые слова:
геморрагический васкулит, нефропатия, иммуноглобулин А, система
комплемента, цитокины, активность тромбоцитов
INTRODUCTION
Hemorrhagic vasculitis (HV) or Henoch-Schönlein purpura is an immune complex-dependent
small-vessel vasculitis, the most frequent systemic vasculitis of children and adolescents [1].
Cutaneous purpura, arthralgia, gastrointestinal syndromes, and renal disease are its principal
manifestations. Nephropathy development is the most severe complication of HV, occurring in
20-60% of patients and affecting long-term outcome [2]. Studies conducted within the Republic
of Uzbekistan confirm renal involvement in 35% of HV children, with this symptom being based
on regional characteristics [3].
Current studies confirm that nephropathy development in HV is a result of complex interactions
between various immune-hematological factors. Defective IgA production, complement system
activation, release of inflammatory cytokines, and platelet dysfunction are the key pathological
features that collectively result in glomerular damage and progressive renal dysfunction. Russian
investigators' large-scale research indicates that IgA nephropathy development mechanisms are
multifactorial in nature and are due to both genetic and environmental factors [4]. Understanding
these mechanisms is critical for the development of directed therapeutic approaches and
improved patient outcomes.
Early diagnosis of immune-hematological predictors of nephropathy development cannot be
overvalued, as it can avoid damage to the kidneys that is not reversible and the progression of
chronic kidney disease. Longitudinal observational research in the Russian Federation indicates
that 85% of patients detected and appropriately treated in early stages have favorable long-term
prognosis. Central Asian regional population studies determine specific genetic polymorphisms
affecting disease susceptibility and disease progression patterns, for which population-related
research approaches are necessary.
METHODOLOGY AND LITERATURE ANALYSIS
This comprehensive literature review was conducted through systematic analysis of peer-
reviewed publications. The analytical framework employed in this review encompasses several
key methodological approaches. First, systematic evaluation of immunoglobulin profiles,
particularly IgA subclasses and their glomerular deposition patterns, was examined across
INTERNATIONAL JOURNAL
OF MEDICAL SCIENCES
ISSN NUMBER: 2692 - 5206
Volume 5,September,2025
40
multiple studies to establish consistent patterns associated with nephropathy development.
Second, complement system analysis focused on classical and alternative pathway components,
their activation patterns, and correlation with renal involvement severity. Third, cytokine profile
assessment included pro-inflammatory and anti-inflammatory mediators, their temporal
variations, and relationship with disease progression. Fourth, hematological parameter evaluation
encompassed platelet function, coagulation factors, and endothelial markers associated with
microvascular damage.
Russian Federation research findings demonstrate that IgA immunoglobulins, specifically IgA1
subclass with aberrant galactosylation, represent the primary pathogenic factor in HV
nephropathy [5]. These abnormal IgA molecules form immune complexes that deposit
preferentially in glomerular mesangium, initiating inflammatory cascades leading to glomerular
damage. Complement system activation, particularly through the alternative pathway, amplifies
the inflammatory response and contributes to tissue injury. Studies consistently demonstrate that
patients developing nephropathy exhibit significantly higher levels of circulating IgA-containing
immune complexes compared to those without renal involvement.
Research conducted in Uzbek medical institutions reveals that clinical manifestations of HV and
immune indicators among the local population correspond with international data, although
certain genetic characteristics exist [6]. Regional studies indicate that a comprehensive approach
is necessary for early identification of patients at high risk of nephropathy development in local
conditions. These findings emphasize the importance of population-specific biomarker validation
and risk stratification protocols.
RESULTS AND DISCUSSION
Analysis of available evidence reveals distinct immune-hematological patterns associated with
nephropathy development in hemorrhagic vasculitis patients. The most consistent finding across
multiple studies is the elevation of serum IgA levels, particularly the IgA1 subclass, in patients
who subsequently develop renal complications [7]. These elevated IgA levels correlate directly
with the severity of glomerular involvement and long-term renal outcomes.
Immunohistochemical analysis of renal biopsies consistently demonstrates predominant IgA
deposition in glomerular mesangium, often accompanied by C3 complement and fibrin deposits.
Comprehensive studies conducted in the Russian Federation demonstrate that complement
system alterations represent another crucial aspect of the pathophysiological process. Patients
with HV nephropathy demonstrate significantly reduced serum levels of C3 and C4 complement
components, indicating active complement consumption during the inflammatory process [8].
The alternative complement pathway appears particularly important, with factor B and properdin
levels showing inverse correlation with nephropathy severity. These findings suggest that
complement activation contributes to glomerular damage through direct cytotoxic effects and
enhancement of inflammatory cell recruitment.
Cytokine profile analysis reveals a predominantly pro-inflammatory pattern in patients
developing nephropathy. Research conducted in Russian pediatric centers demonstrates elevated
levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β)
consistently observed in patients with renal involvement compared to those with isolated
INTERNATIONAL JOURNAL
OF MEDICAL SCIENCES
ISSN NUMBER: 2692 - 5206
Volume 5,September,2025
41
cutaneous manifestations [9]. These cytokines promote endothelial activation, increase vascular
permeability, and facilitate immune complex deposition in glomerular capillaries. Conversely,
anti-inflammatory mediators such as interleukin-10 (IL-10) and transforming growth factor-beta
(TGF-β) show variable patterns, with some studies suggesting inadequate compensatory
responses in patients developing severe nephropathy.
Hematological parameters demonstrate significant alterations in HV patients with nephropathy.
Studies from Uzbek medical centers reveal platelet function abnormalities, including increased
platelet aggregation and enhanced release of pro-thrombotic mediators, contributing to
microvascular thrombosis and glomerular damage [10]. Coagulation system activation,
evidenced by elevated fibrinogen levels and shortened activated partial thromboplastin time,
reflects the prothrombotic state characteristic of severe vasculitis. Endothelial dysfunction
markers, including von Willebrand factor and soluble intercellular adhesion molecule-1, show
significant elevation in nephropathy patients, indicating widespread microvascular involvement.
Therapeutic implications of these findings are substantial. The identification of specific immune-
hematological patterns associated with nephropathy risk enables more targeted treatment
approaches. Research from Central Asian medical institutions indicates that patients
demonstrating high-risk profiles may benefit from earlier and more intensive
immunosuppressive therapy, potentially preventing irreversible renal damage. Additionally,
monitoring of specific biomarkers may guide treatment duration and intensity, optimizing
therapeutic outcomes while minimizing adverse effects.
CONCLUSION
The comprehensive analysis of immune-hematological features in hemorrhagic vasculitis
patients reveals distinct patterns associated with nephropathy development. Elevated IgA levels,
particularly IgA1 with aberrant glycosylation, represent the primary pathogenic mechanism,
while complement system activation and pro-inflammatory cytokine elevation contribute to
glomerular damage progression. Hematological abnormalities, including platelet dysfunction and
coagulation system activation, further exacerbate microvascular injury. These findings support
the implementation of immune-hematological monitoring as an integral component of patient
management, enabling early identification of nephropathy risk and guiding targeted therapeutic
interventions. Future research should focus on developing standardized protocols for biomarker
assessment and establishing evidence-based treatment algorithms based on individual risk
profiles. The integration of immune-hematological parameters into clinical decision-making
represents a promising approach for improving long-term outcomes in hemorrhagic vasculitis
patients across diverse populations.
REFERENCES
1.
Jennette, J.C., Falk, R.J., Bacon, P.A., et al. (2013). 2012 revised International Chapel
Hill Consensus Conference Nomenclature of Vasculitides.
Arthritis & Rheumatism
, 65(1), 1-11.
2.
Davin, J.C., & Coppo, R. (2014). Henoch-Schönlein purpura nephritis in children.
Nature
Reviews Nephrology
, 10(10), 563-573.
INTERNATIONAL JOURNAL
OF MEDICAL SCIENCES
ISSN NUMBER: 2692 - 5206
Volume 5,September,2025
42
3.
Aminova, G.N., & Rakhimova, N.S. (2020). Clinical and epidemiological characteristics
of hemorrhagic vasculitis in children in Uzbekistan.
Journal of Pediatric Nephrology
, 15(3),
234-240.
4.
Игнатова, М.С., & Вельтищев, Ю.Е. (2019). Иммунопатогенез нефрита при
геморрагическом васкулите у детей.
Педиатрия
, 98(4), 45-52.
5.
Moldoveanu, Z., Wyatt, R.J., Lee, J.Y., et al. (2007). Patients with IgA nephropathy have
increased serum galactose-deficient IgA1 levels.
Kidney International
, 71(11), 1148-1154.
6.
Юсупова, Д.М., & Каримова, З.Х. (2021). Особенности течения пурпуры
Шенлейна-Геноха у детей узбекской популяции.
Детская нефрология
, 25(2), 78-84.
7.
López-Mejías, R., Genre, F., Sevilla-Pérez, B., et al. (2018). Genetics of
immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated systematic
review.
Autoimmunity Reviews
, 17(3), 301-315.
8.
Соколова, Л.В., Петрова, И.А., & Смирнов, А.В. (2018). Роль системы комплемента
в развитии нефрита при геморрагическом васкулите.
Нефрология
, 22(5), 67-74.
9.
Кучеренко, А.Г., Багдасарова, И.В., & Длин, В.В. (2019). Цитокиновый профиль
при геморрагическом васкулите с поражением почек у детей.
Педиатрическая нефрология
,
23(1), 28-35.
10.
Narzullayev, U.N., & Sharipova, M.A. (2022). Hemostatic disorders in children with
Henoch-Schönlein purpura nephritis.
Central Asian Journal of Pediatrics
, 8(2), 145-152.
